While trials of the procedure are at the pre-clinical stage, researchers are looking to launch human trials treating specific forms of muscular dystrophy such as oculopharyngeal dystrophy within the next three to five years.
'/>"/>
| Contact: Steve Offner s.offner@unsw.edu.au 61-293-858-107 University of New South Wales Source:Eurekalert |